These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
136 related articles for article (PubMed ID: 18846348)
1. Detection of V, III and I type collagens of dermal tissues in skin lesions of patients with systemic sclerosis and its implication. Liu T; Zhang J J Huazhong Univ Sci Technolog Med Sci; 2008 Oct; 28(5):599-603. PubMed ID: 18846348 [TBL] [Abstract][Full Text] [Related]
2. [Expression and distribution of type I, III and V collagens in skin lesions from patients with systemic sclerosis]. Liu T; Zhang J Sichuan Da Xue Xue Bao Yi Xue Ban; 2008 Sep; 39(5):748-52. PubMed ID: 19024305 [TBL] [Abstract][Full Text] [Related]
3. Abnormal collagen V deposition in dermis correlates with skin thickening and disease activity in systemic sclerosis. Martin P; Teodoro WR; Velosa AP; de Morais J; Carrasco S; Christmann RB; Goldenstein-Schainberg C; Parra ER; Katayama ML; Sotto MN; Capelozzi VL; Yoshinari NH Autoimmun Rev; 2012 Sep; 11(11):827-35. PubMed ID: 22406224 [TBL] [Abstract][Full Text] [Related]
4. Collagen V α1 Chain Decrease in Papillary Dermis from Early Systemic Sclerosis: A New Proposal in Cutaneous Fibrosis Molecular Structure. de Morais J; Velosa APP; Andrade PC; Frediani D; Carrasco S; Queiroz ZAJ; Martin P; Saito RF; Elias V; Goldenstein-Schainberg C; Chammas R; Sampaio-Barros PD; Capelozzi VL; Teodoro WR Int J Mol Sci; 2022 Oct; 23(20):. PubMed ID: 36293511 [TBL] [Abstract][Full Text] [Related]
5. Scleroderma-like remodeling induced by type V collagen. Bezerra MC; Teodoro WR; de Oliveira CC; Velosa AP; Ogido LT; Gauditano G; Parra ER; Capelozzi VL; Yoshinari NH Arch Dermatol Res; 2006 Jul; 298(2):51-7. PubMed ID: 16710740 [TBL] [Abstract][Full Text] [Related]
6. Collagen turnover is diminished by different clones of skin fibroblasts from early- but not late-stage systemic sclerosis. Zurita-Salinas CS; Krötzsch E; Díaz de León L; Alcocer-Varela J Rheumatol Int; 2004 Sep; 24(5):283-90. PubMed ID: 14600784 [TBL] [Abstract][Full Text] [Related]
7. Identification of Autoimmunity to Peptides of Collagen V α1 Chain as Newly Biomarkers of Early Stage of Systemic Sclerosis. Velosa APP; Brito L; de Jesus Queiroz ZA; Carrasco S; Tomaz de Miranda J; Farhat C; Goldenstein-Schainberg C; Parra ER; de Andrade DCO; Silva PL; Capelozzi VL; Teodoro WR Front Immunol; 2020; 11():604602. PubMed ID: 33643291 [TBL] [Abstract][Full Text] [Related]
8. Abnormal collagen deposition in synovia after collagen type V immunization in rabbits. Ogido LT; Teodoro WR; Velosa AP; de Oliveira CC; Parra ER; Capelozzi VL; Yoshinari NH Histol Histopathol; 2008 Mar; 23(3):263-9. PubMed ID: 18072083 [TBL] [Abstract][Full Text] [Related]
9. Elevated expression of type VII collagen in the skin of patients with systemic sclerosis. Regulation by transforming growth factor-beta. Rudnicka L; Varga J; Christiano AM; Iozzo RV; Jimenez SA; Uitto J J Clin Invest; 1994 Apr; 93(4):1709-15. PubMed ID: 7512991 [TBL] [Abstract][Full Text] [Related]
10. UVA irradiation following treatment with topical 8-methoxypsoralen improves bleomycin-induced scleroderma in a mouse model, by reducing the collagen content and collagen gene expression levels in the skin. Hayashi S; Ikeda M; Kitamura Y; Hamasaki Y; Hatamochi A J Dermatol Sci; 2012 Jul; 67(1):20-5. PubMed ID: 22486844 [TBL] [Abstract][Full Text] [Related]
11. Expression of decorin and collagens I and III in different layers of human skin in vivo: a laser capture microdissection study. Lochner K; Gaemlich A; Südel KM; Venzke K; Moll I; Knott A; Stäb F; Wenck H; Döring O; Böttger M; Gallinat S Biogerontology; 2007 Jun; 8(3):269-82. PubMed ID: 17146610 [TBL] [Abstract][Full Text] [Related]
12. [Quantification of type I and III collagen content in normal human skin in different age groups]. Rong YH; Zhang GA; Wang C; Ning FG Zhonghua Shao Shang Za Zhi; 2008 Feb; 24(1):51-3. PubMed ID: 18512563 [TBL] [Abstract][Full Text] [Related]
13. MicroRNA-29, a key regulator of collagen expression in systemic sclerosis. Maurer B; Stanczyk J; Jüngel A; Akhmetshina A; Trenkmann M; Brock M; Kowal-Bielecka O; Gay RE; Michel BA; Distler JH; Gay S; Distler O Arthritis Rheum; 2010 Jun; 62(6):1733-43. PubMed ID: 20201077 [TBL] [Abstract][Full Text] [Related]
14. The effect of extracorporeal photochemotherapy on alpha1(I) and alpha1(III) procollagen mRNA expression in systemic sclerosis skin tissue. Ohtsuka T; Okita H; Yamakage A; Yamazaki S Arch Dermatol Res; 2002 Feb; 293(12):642-5. PubMed ID: 11875648 [No Abstract] [Full Text] [Related]
15. Collagen V nasal tolerance in experimental model of systemic sclerosis. Velosa AP; Teodoro WR; de Oliveira CC; Dos Santos Filho A; Moutinho RF; Santos AG; Vendramini MB; Bueno C; Parra ER; Capelozzi VL; Yoshinari NH Arch Dermatol Res; 2007 Jul; 299(4):177-89. PubMed ID: 17297604 [TBL] [Abstract][Full Text] [Related]
16. Angiotensin II in the lesional skin of systemic sclerosis patients contributes to tissue fibrosis via angiotensin II type 1 receptors. Kawaguchi Y; Takagi K; Hara M; Fukasawa C; Sugiura T; Nishimagi E; Harigai M; Kamatani N Arthritis Rheum; 2004 Jan; 50(1):216-26. PubMed ID: 14730619 [TBL] [Abstract][Full Text] [Related]
17. Localization of endothelin-1 and its binding sites in scleroderma skin. Vancheeswaran R; Azam A; Black C; Dashwood MR J Rheumatol; 1994 Jul; 21(7):1268-76. PubMed ID: 7525957 [TBL] [Abstract][Full Text] [Related]
18. Mutant fibrillin 1 from tight skin mice increases extracellular matrix incorporation of microfibril-associated glycoprotein 2 and type I collagen. Lemaire R; Farina G; Kissin E; Shipley JM; Bona C; Korn JH; Lafyatis R Arthritis Rheum; 2004 Mar; 50(3):915-26. PubMed ID: 15022335 [TBL] [Abstract][Full Text] [Related]
19. Collagen types I, III, and V in human embryonic and fetal skin. Smith LT; Holbrook KA; Madri JA Am J Anat; 1986 Apr; 175(4):507-21. PubMed ID: 3521252 [TBL] [Abstract][Full Text] [Related]
20. Systemic sclerosis Th2 cells inhibit collagen production by dermal fibroblasts via membrane-associated tumor necrosis factor alpha. Chizzolini C; Parel Y; De Luca C; Tyndall A; Akesson A; Scheja A; Dayer JM Arthritis Rheum; 2003 Sep; 48(9):2593-604. PubMed ID: 13130479 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]